Tags

Type your tag names separated by a space and hit enter

Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study.
Support Care Cancer. 2012 Mar; 20(3):641-5.SC

Abstract

PURPOSE

We explored regret in thyroid cancer patients, relating to the decision to accept or reject adjuvant radioactive iodine treatment.

METHODS

We studied patients with a recent diagnosis of early stage papillary thyroid carcinoma, in whom treatment decisions on adjuvant radioactive iodine had been finalized. Participants completed a Decision Regret Scale questionnaire. We asked the participants to identify who made the final decision about radioactive iodine treatment. We explored the relationship between decision regret and a) degree of patient involvement in decision-making and b) receipt of radioactive iodine treatment.

RESULTS

We included 44 individuals, more than half of whom received adjuvant radioactive iodine treatment (26/44). Decision regret was generally low (mean 22.1, standard deviation [SD] 13.0). Participants reported that the final treatment decision was made by the following: patient and doctor (52.3%, 23/44), completely the patient (27.3%, 12/44), or completely the physician (20.5%, 9/44). Decision regret significantly differed according to who made the final decision: the patient (mean 19.0, SD 11.3), patient and doctor (mean 19.5, SD 7.4), and the doctor (mean 32.9, SD 20.37) (F = 4.569; degrees of freedom = 2, 41; p = 0.016). There was no significant difference in decision regret between patients who received radioactive iodine and those who did not (mean difference -2.5; 95% confidence interval -10.6, 5.6; p = 0.540).

CONCLUSION

Thyroid cancer patients who reported being involved in the final treatment decision on adjuvant radioactive iodine had less regret than those who did not.

Authors+Show Affiliations

Division of Endocrinology, Department of Medicine, University Health Network-Toronto General Hospital, 200 Elizabeth Street, 12 EN-212, Toronto, Ontario, Canada M5G 2C4. sawkaam@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Controlled Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22072050

Citation

Sawka, A M., et al. "Thyroid Cancer Patients' Involvement in Adjuvant Radioactive Iodine Treatment Decision-making and Decision Regret: an Exploratory Study." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 20, no. 3, 2012, pp. 641-5.
Sawka AM, Straus S, Gafni A, et al. Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study. Support Care Cancer. 2012;20(3):641-5.
Sawka, A. M., Straus, S., Gafni, A., Meiyappan, S., David, D., Rodin, G., Brierley, J. D., Tsang, R. W., Thabane, L., Rotstein, L., Ezzat, S., & Goldstein, D. P. (2012). Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 20(3), 641-5. https://doi.org/10.1007/s00520-011-1302-x
Sawka AM, et al. Thyroid Cancer Patients' Involvement in Adjuvant Radioactive Iodine Treatment Decision-making and Decision Regret: an Exploratory Study. Support Care Cancer. 2012;20(3):641-5. PubMed PMID: 22072050.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study. AU - Sawka,A M, AU - Straus,S, AU - Gafni,A, AU - Meiyappan,S, AU - David,D, AU - Rodin,G, AU - Brierley,J D, AU - Tsang,R W, AU - Thabane,L, AU - Rotstein,L, AU - Ezzat,S, AU - Goldstein,D P, Y1 - 2011/11/10/ PY - 2011/04/28/received PY - 2011/10/25/accepted PY - 2011/11/11/entrez PY - 2011/11/11/pubmed PY - 2012/6/9/medline SP - 641 EP - 5 JF - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer JO - Support Care Cancer VL - 20 IS - 3 N2 - PURPOSE: We explored regret in thyroid cancer patients, relating to the decision to accept or reject adjuvant radioactive iodine treatment. METHODS: We studied patients with a recent diagnosis of early stage papillary thyroid carcinoma, in whom treatment decisions on adjuvant radioactive iodine had been finalized. Participants completed a Decision Regret Scale questionnaire. We asked the participants to identify who made the final decision about radioactive iodine treatment. We explored the relationship between decision regret and a) degree of patient involvement in decision-making and b) receipt of radioactive iodine treatment. RESULTS: We included 44 individuals, more than half of whom received adjuvant radioactive iodine treatment (26/44). Decision regret was generally low (mean 22.1, standard deviation [SD] 13.0). Participants reported that the final treatment decision was made by the following: patient and doctor (52.3%, 23/44), completely the patient (27.3%, 12/44), or completely the physician (20.5%, 9/44). Decision regret significantly differed according to who made the final decision: the patient (mean 19.0, SD 11.3), patient and doctor (mean 19.5, SD 7.4), and the doctor (mean 32.9, SD 20.37) (F = 4.569; degrees of freedom = 2, 41; p = 0.016). There was no significant difference in decision regret between patients who received radioactive iodine and those who did not (mean difference -2.5; 95% confidence interval -10.6, 5.6; p = 0.540). CONCLUSION: Thyroid cancer patients who reported being involved in the final treatment decision on adjuvant radioactive iodine had less regret than those who did not. SN - 1433-7339 UR - https://www.unboundmedicine.com/medline/citation/22072050/Thyroid_cancer_patients'_involvement_in_adjuvant_radioactive_iodine_treatment_decision_making_and_decision_regret:_an_exploratory_study_ L2 - https://dx.doi.org/10.1007/s00520-011-1302-x DB - PRIME DP - Unbound Medicine ER -